Dementia -associated mortality and its predictors among older adults in sub-Saharan Africa: results from a 2-year follow-up in Congo (the EPIDEMCA-FU study) by Samba, Harielle et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1093/ageing/afw097
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Samba, H., Guerchet, M. M., Ndamba-Bandzouzi, B., Mbelesso, P., Lacroix, P., Dartigues, J. F., & Preux, P-M.
(2016). Dementia -associated mortality and its predictors among older adults in sub-Saharan Africa: results from
a 2-year follow-up in Congo (the EPIDEMCA-FU study). Age and Ageing. DOI: 10.1093/ageing/afw097
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 06. Nov. 2017
1 
 
Dementia-associated mortality and its predictors among older adults in sub-Saharan 1 
Africa: results from a two-year follow-up in Congo (the EPIDEMCA-FU study). 2 
Harielle SAMBA 1,2, Maëlenn GUERCHET 1, 2,3, Bébène NDAMBA BANDZOUZI 1,4, Pascal MBELESSO 1,5, 3 
Philippe LACROIX 1,6, Jean-François DARTIGUES 7, Pierre-Marie PREUX 1,2,8 and the EPIDEMCA group. 4 
 5 
Affiliations  6 
1- INSERM, UMR_S U1094, Tropical Neuroepidemiology, Limoges, France 7 
2- Univ. Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical 8 
Neurology, CNRS FR 3503 GEIST, F-87000 Limoges, France 9 
3- King’s College London, Centre for Global Mental Health, Institute of Psychiatry, Psychology and 10 
Neuroscience, Health Service and Population Research Department, London , UK 11 
4- Dept. of Neurology, Brazzaville University Hospital, Brazzaville, Republic of Congo  12 
5- Dept. of Neurology, Amitié Hospital, Bangui, Central African Republic 13 
6- CHU, Vascular Medicine Unit, F-87000 Limoges, France 14 
7- INSERM U897, Victor Segalen Bordeaux II University, Bordeaux, France 15 
8- CHU, CEBIMER, Limoges, France 16 
 17 
18 
2 
 
Abstract 19 
Background: Between 2001 and 2012 we carried out a study of dementia prevalence in 20 
central Africa throughout the EPIDEMCA (Epidemiology of Dementia in Central Africa) 21 
programme.  22 
Objective: To assess dementia related mortality among Congolese older people from the 23 
EPIDEMCA study after two years of follow-up. 24 
Design: Longitudinal population-based cohort study. 25 
Setting: Gamboma and Brazzaville, Republic of Congo. 26 
Methods: Older participants were traced and interviewed in rural and urban Congo annually 27 
between 2012 and 2014. DSM-IV and NINCDS-ADRDA criteria were required for dementia 28 
diagnosis. Data on vital status were collected throughout the follow-up. Cox proportional 29 
hazards model was used to assess the link between baseline dementia diagnosis and mortality 30 
risk. 31 
Results: Of 1,029 participants at baseline, 910 (88.4%) have a complete cognitive diagnosis. 32 
There were 791 participants (76.87%) with normal cognition, 56 (5.44%) with MCI, and 63 33 
(6.12%) with dementia. After two years of follow-up, 101 (9.8%) participants had died. 34 
Compared to participants with normal cognition, mortality risk was more than 2.5 times 35 
higher among those with dementia (HR= 2.53, 95% CI: 1.42-4.49, p=0.001). Among those 36 
with dementia, only clinical severity of dementia was associated with an additional increased 37 
mortality risk (HR=1.91; CI 95%, 1.23-2.96; p=0.004). Age (per 5-year increase), male sex 38 
and living in an urban area were independently associated with increased mortality risk across 39 
the full cohort. 40 
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Conclusion: Among Congolese older adults, dementia is associated with increased mortality 41 
risk. Our results highlight the need for targeted health policies and strategies for dementia care 42 
in sub-Saharan Africa (SSA). 43 
 44 
Keywords: Dementia, mortality, older adults, sub-Saharan Africa, Republic of Congo 45 
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Introduction 47 
The African population is ageing at an unprecedented rate. Age-related diseases like 48 
dementia, including Alzheimer’s disease (AD), are becoming a major public health issue [1]. 49 
It is estimated that 44.4 million people worldwide were living with dementia in 2013. This 50 
number is predicted to reach 75.6 million in 2030 and 135.5 million in 2050 [2]. The bulk of 51 
the projected increase in the number of people living with dementia will take place in Low 52 
and Middle Income Countries (LMIC), where over 70% of people with dementia are expected 53 
to live in 2040 [3]. This is in part due to rising numbers of people with dementia in sub-54 
Saharan Africa (SSA) [4]. 55 
Longitudinal data suggest that dementia is associated with increased mortality risk [5 - 6 - 7]. 56 
Despite the magnitude of the situation, a low level of public understanding about dementia 57 
persists in LMIC and even more in SSA. Mortality data are useful for understanding the 58 
epidemiology and disease burden of dementia, and studies investigating the association 59 
between dementia and mortality in Africa are therefore of value. 60 
People suffering from dementia die considerably earlier than those without [8 - 9 - 10]. 61 
Reported survival time varies from three to ten years from the onset of symptoms or from 62 
diagnosis of dementia [11]. Within cohorts of people with dementia, age, male sex and 63 
disease severity are commonly associated with mortality risk [10].  64 
To date, the only SSA countries where dementia-related mortality has been documented are 65 
Nigeria and Tanzania. These two studies report a dementia-related mortality risk of 2.83 after 66 
five years of follow-up and 6.33 after four years respectively among Yoruba older people with 67 
dementia and Tanzanian older people [5 - 12].  68 
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The EPIDEMCA-FU programme (Epidemiology of Dementia in Central Africa – Follow-Up) 69 
offers an opportunity to assess dementia-related mortality in a Congolese population-based 70 
cohort. At baseline, the crude prevalence was estimated at 5.67% (95% CI= 3.85 - 8.00) and 71 
6.60% (95% CI= 4.58 - 9.04) respectively for Gamboma (rural area) and Brazzaville (urban 72 
area) [13].  73 
In this survey, we assess the link between dementia and two-year mortality in the older people 74 
population of Congo. We also investigate which factors are predictors of mortality among 75 
people with dementia. 76 
 77 
Methods 78 
Study design and participants 79 
Between 2011 and 2012, a population-based study of dementia prevalence and its associated 80 
factors in Central Africa (EPIDEMCA) was carried out [3]. Around 2,000 participants aged 81 
65 and above living in Central African Republic (CAR) and Republic of Congo (ROC) were 82 
interviewed. The full protocol of the EPIDEMCA study (including data collection, variable 83 
definition and dementia diagnosis) has been described elsewhere [3]. In order to assess 84 
dementia-related mortality in this population, we designed the EPIDEMCA-FU study. 85 
Participants from EPIDEMCA were followed up for two years after the prevalence study. The 86 
two-year follow-up was limited to participants living in ROC. Unfortunately, due to the 87 
ongoing political crisis, follow-up of CAR participants was not feasible.  88 
EPIDEMCA-FU followed up 1,029 participants aged 65 and above living in Congo between 89 
2012 and 2014: 529 participants (51.4%) in Gamboma (rural) and 500 (48.6%) in Brazzaville 90 
(urban). 91 
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The whole cohort was followed up for two years after the initial assessment or until death if 92 
they died before the end of the study period. Information on vital status was obtained every 93 
year during the follow-up study. Dementia cases were all prevalent at baseline (i.e. diagnosed 94 
during the prevalence survey as no prior diagnosis of dementia was recorded). 95 
Baseline data collection 96 
At baseline, data were collected using a standardized questionnaire administered at home by 97 
trained investigators. All questions and tests were adapted, back-translated and pretested in 98 
the local languages (Lari, Lingala, and Kituba). The interview included items about 99 
sociodemographic characteristics (age ascertained by official documents, from an informant 100 
or through a local event calendar; sex; marital status; education level), physical health 101 
(hypertension, diabetes, nutritional status and peripheral artery disease), lifestyle (alcohol and 102 
tobacco consumption), depressive symptomatology (according to the Geriatric Mental State 103 
version B3 (GMS-AGECAT) [3], and a functional assessment.  104 
Diagnostic procedure and criteria for dementia 105 
Cognitive disorders were assessed at baseline through a two-phase screening and diagnostic 106 
procedure. The Community Screening Interview for Dementia (CSI-D) [14] was administered 107 
to identify suspected cases of dementia. All participants obtaining a poor performance on the 108 
CSI-D (COGSCORE ≤ 24.5) were referred for detailed clinical assessment with a neurologist. 109 
A neurological examination was performed, including history of stroke and depressive 110 
disorders (assessed by specific questions). Orientation skills and daily living activities were 111 
also investigated in order to evaluate dependence. Neurological assessments also employed 112 
additional cognitive tests: the Free and Cued Selective Reminding Test [15] (oral version with 113 
image), Zazzo’s cancellation task [16] and Isaac’s Set Test of verbal fluency [17]. During this 114 
phase, neurologists had access to participants’ health booklets if available. 115 
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Dementia diagnosis was made according to the DSM-IV criteria [18] and AD was diagnosed 116 
according to the clinical criteria proposed by the NINCDS-ADRDA (National Institute of 117 
Neurological and Communicative Disorders and Stroke and the AD and Related Disorders 118 
Association) [19]. The severity of dementia was evaluated by the CDR (Clinical Dementia 119 
Rating Scale) [20]. Mild cognitive impairment (MCI) was diagnosed according to Petersen 120 
criteria [21]. An experienced neurologist reviewed all medical records and test performances 121 
for all the participants assessed at the second stage of the study in order to reach a consensus. 122 
In case of insufficient information to reach a diagnosis, the participant was coded 123 
unclassifiable. 124 
Outcomes  125 
The vital status of all participants two years after baseline diagnosis was assessed. In case of 126 
death a verbal autopsy with close relatives was performed. Date of death was recorded; if only 127 
the month of death was known, an arbitrary date set at the 15th of the month was assigned. 128 
The history of illness before death and probable cause of death were sought. We enquired 129 
whether subjects had died due to cardiovascular disease including stroke, cancer, infection, or 130 
other causes (accident, malaria, unknown cause, etc.). When we were unable to contact the 131 
participant, information on vital status was obtained from close relatives. When participants 132 
had moved away, we sought to contact them, even outside the study area. All participants for 133 
whom vital status could not be reliably confirmed were considered lost to follow-up. 134 
Statistical analysis 135 
Data were analysed using Stata software, version 10.1 (Stata-Corp, College Station, Texas, 136 
United States).  137 
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Baseline characteristics were compared using Chi2 or Fisher’s exact tests, where appropriate. 138 
The link between two-year mortality and dementia was examined using a multivariate Cox 139 
regression model, with estimations of hazard ratios (HR) and their 95% confidence intervals 140 
(CIs). The model was controlled for age, sex, residency area and comorbidities collected 141 
using Charlson’s index [22]. This model was fitted using two-year vital status as the 142 
dependent variable. Independent variables were those collected during the baseline prevalence 143 
survey: age, sex, residency and other sociodemographic and clinical data. The confounding 144 
effects of covariates were examined individually in unadjusted Cox models. All covariates 145 
with a p value <0.20 in unadjusted Cox model were then selected and included in multivariate 146 
backward step-by-step regression model. 147 
Similarly, we conducted a statistical analysis to assess factors associated with mortality in 148 
people with dementia. For this analysis, the model was fitted using vital status as the 149 
dependent variable. Cognitive status, age, sex, residency, hypertension, diabetes, ABI and 150 
global score of disease severity according to CDR scale were the covariate variables. The 151 
level of significance for all statistical analyses and multivariate models was fixed at 0.05. 152 
Kaplan Meier curves were created according to diagnosis group in order to describe the 153 
impact of dementia on mortality using the date of the screening interview as the starting point 154 
and the date of death or two-year follow-up as the endpoint. Log rank tests were used to 155 
evaluate the equality of survival distribution for dementia. 156 
Ethics  157 
The study was approved by the Congolese ethical committee CERSSA (Comité d’Ethique de 158 
la Recherche en Sciences de Santé) and by an ethics review board (Comité de Protection des 159 
Personnes Sud-Ouest Outre Mer) in France. 160 
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Participants were recruited following informed consent from themselves and/or from 161 
relatives.  162 
 163 
164 
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Results 165 
Characteristics of participants 166 
At baseline, the 1029 participants were aged from 65 to 99 years (mean age 73.8 ± 6.8 years), 167 
403 (39.2%) were males and 626 (60.8%) females. Among those, 119 (11.6%) participants 168 
were excluded because of missing information concerning dementia diagnosis. Those were 169 
lost because of moving, death before diagnosis, refusal to participate in the second stage or 170 
unclassifiable after examination (n=8). The final study population included 910 participants 171 
(431 in Gamboma and 479 in Brazzaville). Excluded participants were more likely to be 172 
female (75.2 vs. 58.6%; p<0.001), widowed (68.1 vs 49.0, p=0.001), with lower levels of 173 
education (84.0 vs. 66.4, p<0.001) and rural residency (82.4 vs. 47.4%; p<0.001) (please see 174 
the table Appendix 1 in the supplementary data on the journal website 175 
http://www.ageing.oxfordjournals.org/ ). Very few participants were lost to follow-up (n=43, 176 
i.e.4.2%). No individuals with dementia were identified among the excluded participants. 177 
Table 1 summarizes participant baseline characteristics according to cognitive status. People 178 
with dementia were older (p<0.001), more likely to be underweight (p=0.005), more likely to 179 
be widowed (p<0.001) and less likely to be alcohol consumers (p=0.012).  180 
2-year mortality predictors 181 
In unadjusted Cox analysis, mortality risk was associated with increasing age (5-year bands), 182 
sex, residency area, cognitive status, diabetes, peripheral artery disease, tobacco and alcohol 183 
consumption. After adjustment, the effect of diabetes, peripheral artery disease and tobacco 184 
consumption on the mortality risk disappeared (Table 2). The final model demonstrates a 185 
significant association between cognitive status and mortality risk. Mortality risk was more 186 
than two and a half times higher in the dementia group compared to those with normal 187 
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cognition (HR 2.53; CI 95% 1.42-4.49; p=0.001), but the risk increase was not statistically 188 
significant among those with MCI (HR 1.44, CI 95%, 0.65-3.18; p=0.367). Across the entire 189 
population, old age, male sex and living in an urban area were associated with an increased 190 
mortality risk, while moderate alcohol consumption was associated with decreased risk. 191 
Among those with dementia, only greater disease severity was strongly associated with 192 
increased mortality risk (global CDR score 0.5-1 vs >2) (HR 1.91; CI 95%, 1.23-2.96; 193 
p=0.004) (data not shown). 194 
After two years of follow-up, 101 (11.6%) participants died and at least 16 deaths were 195 
related to cardiovascular diseases. Most of deaths (34.9%, p<0.001) occurred in the dementia 196 
group (please see the table Appendix 2 in the supplementary data on the journal website 197 
http://www.ageing.oxfordjournals.org/ for baseline characteristics). Kaplan-Meir curves were 198 
used to compare survival according to cognitive status (Figure 1). People with dementia had 199 
significantly shorter survival periods than those with MCI and normal cognition (log-rank 200 
test: p<0.001). 201 
 202 
Discussion 203 
In this population-based survey, dementia at baseline was associated with a 2.5 fold mortality 204 
risk, while MCI showed no association with mortality. Age, male sex and living in an urban 205 
area were also associated with mortality risk. When considering just people with dementia, 206 
only disease severity influenced mortality. Our findings are consistent with most studies 207 
highlighting the link between dementia and mortality [10], including previous results from 208 
Nigeria and Tanzania [5 - 12]. 209 
Dementia at baseline was associated with increased mortality risk, with an HR of 2.5. 210 
Previous studies have reported increasing mortality risk in dementia or AD, with HR ranging 211 
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from 1.4 [23] to 5.2 [24]. Among Yoruba older people in Nigeria, dementia was significantly 212 
associated with increased mortality risk, with an HR of 2.8 compared to those without [5]. In 213 
Tanzania, Paddick et al. found that after 4-years of follow-up dementia-related death risk was 214 
about 6.3 compared to those without [12]. Despite differences in study design and follow-up 215 
time, our results are consistent with these previous data. This suggests that dementia has an 216 
important impact on African older adults’ mortality risk. In our study, MCI at baseline was 217 
not associated with increased mortality risk while in Tanzania MCI was associated to 218 
increased risk of death [12]. MCI is recognized as an intermediate stage of dementia [25]. 219 
Previous studies investigating the link between MCI and mortality have found contrasting 220 
results, sometimes observing significant positive associations [7 - 26] or sometimes no 221 
association [27]. In our study this may be due to a lack of statistical power due to the small 222 
number of participants with MCI (n=56) or to the short follow-up time. 223 
Many factors have been reported to predict mortality in people with dementia. Age, sex, 224 
severity of disease and disability are the most commonly-reported factors [10 - 11]. In our 225 
study, only greater disease severity assessed by the CDR scale at baseline was associated with 226 
increased mortality risk in people with dementia. These findings are consistent with previous 227 
studies, which also reported this association [5 - 9 - 25 - 28]; however, greater disease severity 228 
has not always been found to increase mortality risk in people with dementia [28]. Within our 229 
study population, more than 70% of people with dementia who died during the follow-up had 230 
a global CDR score > 2 at the time of diagnosis. High cognitive impairment at the time of 231 
dementia diagnosis probably contributed to an increased risk of death. These results should be 232 
considered with caution, because we did not identify other factors that might explain how 233 
disease severity can be associated with increased mortality among people with dementia.  234 
People with dementia are heavy consumers of health services [29]. Those with a high disease 235 
severity need greater medical care and human assistance because of their dependence. In 236 
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ROC, as in most of LMIC, affected persons do not seek help; even if they do, health-care 237 
services tend not to meet their needs. For people with advanced dementia this situation may 238 
enhance global health deterioration and result in increased mortality risk. Guehne and 239 
colleagues [30] observed that the positive correlation between dementia severity and mortality 240 
was generally reported in studies carried out over at least 5 years. Report of positive 241 
association between disease severity and mortality just after 2 years of follow up, may be 242 
explained by the lack of adequate health care and also by the use of prevalent cases. These 243 
findings encourage the assumption that analyses of dementia mortality may be biased by the 244 
inclusion of more severe cases – usually older, with more comorbidities – who have a higher 245 
risk of death [7 - 14]. 246 
 247 
Limits of the study 248 
We have studied a fairly large cohort of older adults and followed them up for two years. 249 
Unfortunately, more than ten percent of our baseline population was excluded due to missing 250 
data on dementia diagnosis. This is one of the main limits of two-phase design in dementia 251 
diagnosis. The delay between screening and diagnosis increased the number of participants 252 
lost to follow-up and the number of refusals, reducing our study population and probably 253 
affecting the power of our study. The lack of statistical power might have led to an 254 
underestimation of potential relationships between variables and dementia-related mortality. 255 
However, it is important to emphasize the high quality methodology used for diagnosing 256 
dementia cases, and the low rate of loss to follow-up two years after baseline. It would have 257 
been interesting to explore the impact of mortality according to dementia subtype; however, 258 
the lack of imaging for diagnosing dementia subtypes somewhat limited the appreciation of 259 
the various subtypes. 260 
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 262 
Conclusion 263 
In this population-based cohort of older adults from ROC, dementia was associated with 264 
increased mortality among older adults. Among people with dementia, disease severity was 265 
strongly associated with increased mortality risk. These results highlight the contribution of 266 
dementia to older adult mortality. It is therefore important to manage this condition if we are 267 
to avoid premature risk of death in SSA. 268 
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Table 1: Baseline characteristics of 910 included participants according to cognitive status, EPIDEMCA-FU 374 
2012-2014 375 
                         
 Dementia  MCI   Normal   Total P 
value   n %   n %   n %   n % 
Sociodemographic 
characteristics 
                      
Age (year)           <0.001 
   [65-70[ 9 14.29  11 19.64  286 36.16  306 33.63 
 
   [70-75[ 8 12.70  14 25.00  210 26.55  232 25.49 
   [75-80[ 12 19.05  19 33.93  151 19.09  182 20.0 
   [80-85[ 13 20.63  7 12.50  103 13.02  123 13.52 
   ≥85 21 33.33  5 8.93  41 5.18  67 7.36 
Sex a            <0.001 
   Women 49 77.78  45 80.36  439 55.50  533 58.57  
Marital status b           <0.001 
   Single 2 3.23  1 1.79  20 2.53  23 2.54 
    Married 13 20.97  10 17.86  345 43.73  368 40.57 
   Widowed 43 69.35  38 67.86  363 46.01  444 48.95 
   Divorced 4 6.45  7 12.50  61 7.73  72 7.49  
Education b           0.002 
   No formal 
education 
53 85.48  49 87.50  500 63.37  602 66.37 
 
   Has not 
completed 
primary education  
5 8.06  5 8.93  134 16.98  144 15.88 
   Primary 2 3.23  1 1.79  78 9.89  81 8.93 
   Secondary 1 1.61  1 1.79  41 5.20  43 4.74  
   High  1 1.61  0 0.00  36 4.56  37 4.08  
Residency area a           0.199 
   Gamboma 
(rural) 
30 47.62  33 58.93  368 46.52  431 47.36  
Death a b 22 34.92  7 12.50  72 9.56  101 11.58 <0.001 
Probable Causes of death b          0.561 
   CVD 12 80.00  2 66.67  24 54.55  38 61.29  
   Infectious 2 13.33  0 0.00  10 22.73  12 19.35  
   Cancer 0 0.00  0 0.00  5 11.36  5 8.06  
   Others  1 6.67  1 33.33  5 11.36  7 11.30  
Clinical characteristics                     
Hypertension a b 41 67.21  34 60.71  244 31.08  616 68.29 0.436 
Diabetes a b 4 6.56  5 8.93  92 11.87  101 11.32 0.381 
ABI b             0.347 
   ABI≤0.9 10 24.39  11 21.15  117 15.94  138 16.69  
   0.9<ABI<1.4 29 70.73  40 76.92  595 81.06  664 80.29 
 
   ABI ≥  1.4 2 4.88  1 1.92  2 4.88  25 3.02 
BMI (Kg/m2) b           0.005 
   <18.5 23 52.27  21 42.00  208 27.48  252 29.61 
 
   18.5≤ BMI≤  
24.9 
16 36.36  25 50.00  384 50.73  425 49.94 
   25.0≤ BMI≤  4 9.09  3 6.00  106 14.00  113 13.28 
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29.9 
   ≥30 1 2.27  1 2.00  59 7.79  61 7.17  
Life habits                       
Tobacco consumption b          0.372 
   Never  50 80.65  40 71.43  643 81.70  733 80.99 
    Former  4 6.45  4 7.14  48 6.10  56 6.19 
   Current  8 12.90  12 21.43  96 12.20  116 12.82 
Alcohol consumption b          0.012 
   Never  53 96.36  51 91.07  635 80.89  739 82.48 
    Sometimes 1 1.82  1 1.79  38 4.85  40 4.46 
   Regularly 1 1.82   4 13.79   112 14.27   117 13.06 
             
a: omitted category for dichotomic variables 376 
b: denominator may vary due to missing data 377 
ABI: Ankle Brachial Index, BMI: Body Mass Index, CVD: Cardiovascular Disease, MCI: Middle Cognitive 378 
Impairment  379 
 380 
 381 
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Table 2: Two-year mortality associated risk factors, EPIDEMCA-FU 2012-2014 382 
        
 
  
  
 
Unadjusted cox analysis     
Adjusted cox 
multivariate analyses  
(Final model) C 
  
  HR 95% CI P value   HR 95% CI P value 
Age (for a 5 years increase) 
  
     [65-70[ 1 Reference 
  
1 Reference 
 
[70-75[ 
0.98 0.53 - 1.89 
<0.001 
 
0.93 
0.49 - 
1.77 
0.833 
[75-80[ 
0.93 0.53 - 2.00 
 
0.99 
0.50 - 
1.97 
0.986 
[80-85[ 
1.91 1.91 - 5.82 
 
3.13 
1.75 - 
5.61 
<0.001 
>85 2.30 
2.30 - 7.98 
 
3.15 
1.58 - 
6.28 
0.001 
Sex 
 
 
  
   
Women 
1 Reference 
  
3.15 
1.58 - 
6.28 
0.001 
Men 
1.65 1.11 - 2.46 
0.012 
 
2.31 
1.52 - 
3.50 <0.001 
Cognitive status 
  
     Normal 1 Reference 
  
1 Reference 
 
MCI  
1.31 0.60 - 2.84 
<0.0
01 
 
1.44 
0.65 - 
3.18 
0.367 
Dementia 
3.87 2.36 - 6.34 
 
2.53 
1.42 - 
4.49 
0.001 
Residence area 
  
     Gamboma (rural) 1 Reference 
  
1 Reference 
 
Brazzaville (urban) 
1.43 0.95 - 2.14 
0.080 
 
1.62 
1.06 - 
2.45 
0.023 
Education   
  
   
            No formal education 1 Reference 
  
   
            Has not completed 
primary education  
1.04 0.59 - 1.82 
0.874 
    
            Primary 1.44 0.76 - 2.65 
    
            Secondary 0.92 0.36 - 2.37 
    
            High  1.08 0.42 - 2.81 
    
Ankle Brachial index 
  
     No artery disease 1 Reference 
     Peripheral artery disease 1.97 1.19 - 3.28 
0.043  
   Mediacalcosis 1.01 0.24 - 4.16 
 
   BMI (Kg/m2) 
    
   <18.5 1 Reference 
0.739 
 
   18.5≤ BMI≤ 24.9 0.57 0.34 - 0.94 
 
   25.0≤ BMI≤ 29.9 0.98 0.52 - 1.85 
 
   > 30 0.87 0.38 - 1.98 
 
   Hypertension 
    
   No 1 Reference 
  
   Yes 1.16 0.75 - 1.81 0.480 
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Diabete 
  
     No  1 Reference 
     Yes 1.49 0.86 - 2.59 0.171 
    
Tobacco consumption 
  
     Never smoked 1 Reference 
0.241 
 
   Former smoker 0.94 0.40 - 2.19 
 
   Current smoker 0.64 0.34 - 1.33 
 
   Alcohol consumption  
  
     Never smoked 1 Reference 
0.053 
 
1 Reference 
 
Sometimes 
0.65 0.20 - 2.07 
 
0.58 
0.18 - 
1.89 
0.374 
Regularly 
0.41 0.18 - 0.96   0.36 
0.15 - 
0.86 
0.022 
C adjusted for sex, age, residency area, cognitive status, ankle brachial index, alcohol use, and diabetes 383 
HR: Hazard Ratio, CI: Confidence Interval, ABI: Ankle brachial Index, BMI: Body Mass Index MCI: 384 
Middle Cognitive Impairment 385 
 386 
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Figure 1: Survival curves for all-cause mortality at two-years according to dementia 387 
diagnosis group, EPIDEMCA-FU 2012-2014 388 
 389 
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 391 
 392 
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